| __timestamp | Summit Therapeutics Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 6795238 | 7751000 |
| Thursday, January 1, 2015 | 7454247 | 10251000 |
| Friday, January 1, 2016 | 10345862 | 9575000 |
| Sunday, January 1, 2017 | 16984203 | 10912000 |
| Monday, January 1, 2018 | 16187290 | 11049000 |
| Tuesday, January 1, 2019 | 9299233.54 | 11646000 |
| Wednesday, January 1, 2020 | 19232000 | 13265000 |
| Friday, January 1, 2021 | 23611000 | 25805000 |
| Saturday, January 1, 2022 | 26700000 | 35182000 |
| Sunday, January 1, 2023 | 28215000 | 94999000 |
Infusing magic into the data realm
In the competitive landscape of biotechnology, managing operational costs is crucial. This analysis highlights the Selling, General, and Administrative (SG&A) expenses of Summit Therapeutics Inc. and Viridian Therapeutics, Inc. from 2014 to 2023. Over this period, Summit Therapeutics saw a steady increase in SG&A expenses, peaking in 2023 with a 315% rise from 2014. Meanwhile, Viridian Therapeutics experienced a more volatile trajectory, culminating in a staggering 1,126% increase by 2023.
Understanding these trends provides valuable insights into each company's strategic priorities and market positioning, offering a glimpse into their future growth potential.
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Summit Therapeutics Inc.
Selling, General, and Administrative Costs: Vertex Pharmaceuticals Incorporated vs Viridian Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and Summit Therapeutics Inc.
Selling, General, and Administrative Costs: United Therapeutics Corporation vs Summit Therapeutics Inc.
Neurocrine Biosciences, Inc. and Summit Therapeutics Inc.: SG&A Spending Patterns Compared
Intra-Cellular Therapies, Inc. vs Summit Therapeutics Inc.: SG&A Expense Trends
Summit Therapeutics Inc. and HUTCHMED (China) Limited: SG&A Spending Patterns Compared
Comparing Innovation Spending: Summit Therapeutics Inc. and Viridian Therapeutics, Inc.
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs Viridian Therapeutics, Inc. Trends and Insights
Comparing SG&A Expenses: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc. Trends and Insights
BioCryst Pharmaceuticals, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?